Infosys Acquires Minority Stake in Healthcare Deep-tech Firm 4baseCare

The investment is part of Infosys’ strategy to work with AI and DeepTech startups to deliver new solutions.

Indian multinational technology company Infosys has announced an investment of a whopping INR 8 Cr (approximately USD 1.0 Mn) in healthcare and life sciences startup 4baseCare.

The investment, made through the Infosys Innovation Fund, aims to enhance precision oncology solutions powered by AI and analytics.

“The population-specific datasets generated by them powered by tech-driven AI and analytics solutions have immense potential to improve cancer diagnosis, treatment, drug discovery, and development across the Healthcare and Life Sciences ecosystem, improving lives.” Infosys stated, in its regulatory filing.

The investment is part of Infosys’ strategy to work with AI and DeepTech startups to deliver new solutions.

Further, the company said these solutions will help its clients manage business transformations more effectively.

“A minority holding, not exceeding 20% of the outstanding share capital of the company,” the tech giant added.

Bengaluru-based 4baseCare, a precision oncology solutions provider, specializes in developing advanced personalized cancer treatments. The startup utilizes high-tech genomics and next-generation digital health technologies to craft personalized cancer therapies.

The Infosys Innovation Fund focuses on fostering partnerships with AI and deep-tech firms to drive innovation across industries.

Earlier, in August, 4baseCare successfully raised $6 million in Series A funding, led by Yali Capital along with other investors.

With plans to scale up operations, 4baseCare aims to expand its presence in India along with other countries in Asia and the Middle East.

The startup has also announced its goal to establish genomics laboratories in the Philippines, Nepal, and Dubai in the coming months.

These labs will focus on building advanced genomics and digital health solutions, including advanced data analytics, improved clinical insights, and data-driven treatment recommendations.

4baseCare’s innovative approach has garnered attention from industry leaders, including Mathew Cyriac, Founding General Partner of Yali Capital, who highlighted the significant opportunities in the genomics landscape for cancer care.

Stay tuned for more such updates on Digital Health News.